Noncoding RNA as regulators of cardiac fibrosis: current insight and the road ahead.

Research paper by Hui H Tao, Jing-Jing JJ Yang, Wei W Hu, Kai-Hu KH Shi, Zi-Yu ZY Deng, Jun J Li

Indexed on: 21 Jan '16Published on: 21 Jan '16Published in: Pflügers Archiv - European Journal of Physiology


Cardiac fibrosis is an important pathological feature of cardiac remodeling in heart diseases. The molecular mechanisms of cardiac fibrosis are unknown. Genomic analyses estimated that many noncoding DNA regions generate noncoding RNAs (ncRNAs). ncRNAs have emerged as key molecular players in the regulation of gene expression in different biological processes. Recent studies have started to reveal the importance of ncRNAs in heart development and suggest also an involvement in cardiac fibrosis. These molecules are emerging as important regulators of cellular process. Here, we review particularly focuses on the involvement of two large families of ncRNAs, namely microRNAs (miRNAs) and long noncoding RNAs (LncRNAs) in the regulation of cardiac fibrosis. Furthermore, we review the functions and role of ncRNAs in cardiac biology and discuss these reports and the therapeutic potential of ncRNAs for cardiac fibrosis associated with fibroblast activation and proliferation.